Literature DB >> 19057845

Risk factors for cardiovascular disease and endothelin-1 levels in Takayasu arteritis patients.

Alexandre Wagner Silva de Souza1, Henrique Ataíde Mariz, Edgard Torres Reis Neto, Anne Elizabeth Diniz Arraes, Neusa Pereira da Silva, Emília Inoue Sato.   

Abstract

The objective of this study was to evaluate traditional risk factors for cardiovascular disease (CVD) and endothelin-1 (ET-1) levels in Takayasu arteritis (TA) patients. Twenty-two TA patients and 37 controls were evaluated. TA patients had a higher prevalence of hypertension (63.6% vs. 21.6%, p=0.001) and higher levels of triglycerides (129.5 mg/dL+/-70.8 vs. 88.4 mg/dL+/-60.8, p=0.017) than controls. Mean number of CVD risk factors was 1.64+/-1.22 in TA patients and 1.03+/-1.44 among controls, p=0.030. More TA patients presented at least one CVD risk factor when compared to controls (77.2% vs. 51.3%, p=0.048). ET-1 levels were higher in patients than in controls (1.49 pg/mL+/-0.45 vs. 1.27 pg/mL+/-0.32, p=0.034), however no significant difference was found between patients with active and inactive disease. In this study, TA patients presented a higher prevalence of hypertension, higher levels of triglycerides, and ET-1 than controls.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19057845     DOI: 10.1007/s10067-008-1056-0

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  30 in total

1.  Atherosclerosis in Takayasu arteritis.

Authors:  E Seyahi; S Ugurlu; R Cumali; H Balci; N Seyahi; S Yurdakul; H Yazici
Journal:  Ann Rheum Dis       Date:  2006-01-26       Impact factor: 19.103

Review 2.  Mechanisms of ET-1-induced endothelial dysfunction.

Authors:  Marc Iglarz; Martine Clozel
Journal:  J Cardiovasc Pharmacol       Date:  2007-12       Impact factor: 3.105

Review 3.  Takayasu's arteritis: a cell-mediated large-vessel vasculitis.

Authors:  R Rizzi; S Bruno; C Stellacci; R Dammacco
Journal:  Int J Clin Lab Res       Date:  1999

4.  Takayasu arteritis. Treatment and prognosis in a university center in Brazil.

Authors:  E I Sato; D N Lima; B Espirito Santo; F Hata
Journal:  Int J Cardiol       Date:  2000-08-31       Impact factor: 4.164

5.  Serum cytokine profiles and their correlations with disease activity in Takayasu's arteritis.

Authors:  M C Park; S W Lee; Y B Park; S K Lee
Journal:  Rheumatology (Oxford)       Date:  2005-12-13       Impact factor: 7.580

6.  Takayasu's arteritis: a cause of prolonged arterial stiffness.

Authors:  W F Ng; F Fantin; C Ng; F Dockery; R Schiff; K A Davies; C Rajkumar; J C Mason
Journal:  Rheumatology (Oxford)       Date:  2006-01-10       Impact factor: 7.580

7.  Takayasu arteritis in Thailand: clinical and imaging features.

Authors:  N Suwanwela; C Piyachon
Journal:  Int J Cardiol       Date:  1996-08       Impact factor: 4.164

8.  Plasma endothelin-1 levels in Takayasu's arteritis.

Authors:  H Akazawa; U Ikeda; T Kuroda; K Shimada
Journal:  Cardiology       Date:  1996 Jul-Aug       Impact factor: 1.869

Review 9.  Pathological studies on Takayasu arteritis.

Authors:  M Hotchi
Journal:  Heart Vessels Suppl       Date:  1992

10.  Takayasu arteritis.

Authors:  G S Kerr; C W Hallahan; J Giordano; R Y Leavitt; A S Fauci; M Rottem; G S Hoffman
Journal:  Ann Intern Med       Date:  1994-06-01       Impact factor: 25.391

View more
  6 in total

1.  Development of outcome measures for large-vessel vasculitis for use in clinical trials: opportunities, challenges, and research agenda.

Authors:  Haner Direskeneli; Sibel Z Aydin; Tanaz A Kermani; Eric L Matteson; Maarten Boers; Karen Herlyn; Raashid A Luqmani; Tuhina Neogi; Philip Seo; Ravi Suppiah; Gunnar Tomasson; Peter A Merkel
Journal:  J Rheumatol       Date:  2011-07       Impact factor: 4.666

2.  Adenosine induced coronary vasospasm during Rubidium PET myocardial perfusion scan in a patient with Takayasu's Arteritis.

Authors:  Saadia Aslam; Muhammad Khan; Luigi Venetucci; Parthiban Arumugam
Journal:  J Nucl Cardiol       Date:  2016-06-20       Impact factor: 5.952

Review 3.  Takayasu arteritis - epidemiology, pathogenesis, diagnosis and treatment.

Authors:  Dominika Podgorska; Rafal Podgorski; David Aebisher; Piotr Dabrowski
Journal:  J Appl Biomed       Date:  2019-01-09       Impact factor: 1.797

Review 4.  Physical Exercise in Managing Takayasu Arteritis Patients Complicated With Cardiovascular Diseases.

Authors:  Yaxin Zhou; Yuan Feng; Wei Zhang; Hongxia Li; Kui Zhang; Zhenbiao Wu
Journal:  Front Cardiovasc Med       Date:  2021-05-12

5.  Disease-specific factors associated with cardiovascular events in patients with Takayasu arteritis.

Authors:  Oh Chan Kwon; Jung Hwan Park; Yong-Beom Park; Min-Chan Park
Journal:  Arthritis Res Ther       Date:  2020-07-31       Impact factor: 5.156

6.  Management of Takayasu arteritis: a systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis.

Authors:  Ana F Águeda; Sara Monti; Raashid Ahmed Luqmani; Frank Buttgereit; Maria Cid; Bhaskar Dasgupta; Christian Dejaco; Alfred Mahr; Cristina Ponte; Carlo Salvarani; Wolfgang Schmidt; Bernhard Hellmich
Journal:  RMD Open       Date:  2019-09-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.